Global Anti-Obesity Therapeutics Market Growth 2023-2029

Global Anti-Obesity Therapeutics Market Growth 2023-2029

Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of calories. Appetite control is achieved through the use of agonists for appetite suppressing pathways.

LPI (LP Information)' newest research report, the “Anti-Obesity Therapeutics Industry Forecast” looks at past sales and reviews total world Anti-Obesity Therapeutics sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-Obesity Therapeutics sales for 2023 through 2029. With Anti-Obesity Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Obesity Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Anti-Obesity Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Obesity Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Anti-Obesity Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Obesity Therapeutics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Obesity Therapeutics.

The global Anti-Obesity Therapeutics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Geographically, North America captures the largest market share on account of increasing obese population. As per the historical trends, more than one-third of the U.S. population is obese. However, Asia Pacific is anticipated to grow at the fastest rate due to increasing demand for the drugs and awareness about the risk associated with obesity. According to WHO, 13.0% of the population were obese in 2014. In developing countries the rate of childhood obesity is increasing and has been 30.0% higher than that of developed countries.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Obesity Therapeutics market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Centrally Acting Anti-obesity Drugs
Peripherally Acting Anti-obesity Drugs

Segmentation by application
Hospital Use
Clinic Use
Household
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bristol-Myers Squibb
Eisai Company
FlaxoSithKline plc.
Novo Nordisk
Alizyme
BoehringerIngelheim GmbH
Pfizer
Takeda Pharmaceutical
Rhythm Pharmaceuticals
Shionogi USA
Vivus
Zafgen
Norgine Pharmaceuticals Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Anti-Obesity Therapeutics market?

What factors are driving Anti-Obesity Therapeutics market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Anti-Obesity Therapeutics market opportunities vary by end market size?

How does Anti-Obesity Therapeutics break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.